ACE2 and infection: Recently, a humanized mouse model for persistent infection of SARS-CoV-2 was established by delivering human ACE2 to mouse lung tissues using adeno-associated virus and it was proved to recapitulate innate and adaptive human immune responses against SARS-CoV-2 infection up to 28 days after infection (Sefik et al., 2022).